BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/25/2025 4:18:21 PM | Browse: 364 | Download: 955
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 103128
Country India
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance
Manuscript Source Unsolicited Manuscript
All Author List Umashri Sundararaju and Hamrish Kumar Rajakumar
ORCID
Author(s) ORCID Number
Umashri Sundararaju http://orcid.org/0009-0004-6488-4172
Hamrish Kumar Rajakumar http://orcid.org/0009-0008-9642-9915
Funding Agency and Grant Number
Corresponding Author Hamrish Kumar Rajakumar, Department of General Surgery, Government Medical College, Omandurar Government Estate, Wallajah Road, Chennai 600002, Tamil Nādu, India. hamrishkumar2003@gmail.com
Key Words Gastric cancer; Inflammatory markers; Neoadjuvant chemotherapy; Neutrophil-to-lymphocyte ratio; Prognostic biomarker; Survival outcomes
Core Tip The neutrophil-to-lymphocyte ratio (NLR) shows promise as a prognostic biomarker for gastric cancer, but its clinical use faces challenges, such as inconsistent cut-off values and unclear timing for measurement. Standardizing these factors, exploring additional inflammatory markers, and refining research methodologies will enhance NLR’s reliability and clinical utility in managing gastric cancer.
Publish Date 2025-03-25 16:18
Citation

Sundararaju U, Rajakumar HK. Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer: Enhancing clinical relevance. World J Gastrointest Oncol 2025; 17(4): 103128

URL https://www.wjgnet.com/1948-5204/full/v17/i4/103128.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i4.103128
Full Article (PDF) WJGO-17-103128-with-cover.pdf